Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients.
Fujita K, Mimura S, Iwama H, Nakahara M, Oura K, Tadokoro T, Nomura T, Tani J, Yoneyama H, Morishita A, Oryu M, Himoto T, Nishitsuji H, Shimotohno K, Omata M, Masaki T.
Fujita K, et al. Among authors: omata m.
Int J Mol Sci. 2018 Jul 2;19(7):1940. doi: 10.3390/ijms19071940.
Int J Mol Sci. 2018.
PMID: 30004437
Free PMC article.
Clinical Trial.